【小分子】《Terray》完成超額認購1.2億美元B輪，將小分子藥物生成式AI「tNova」推向臨床

 【小分子】《Terray》完成超額認購1.2億美元B輪，將小分子藥物的生成式AI「tNova」推向臨床

 文章出處  

Businesswire 

 

 原文標題  

Terray Therapeutics Closes Oversubscribed $120M Series B to Advance Its Generative AI Pipeline of Small Molecule Therapeutics to the Clinic 

 

 Twitter  

https://x.com/aimedadviser/status/1848162151070048590 

 

 文章序號  

6487 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2024 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.